Kamada Ltd at Jefferies Virtual Plasma Summit Transcript
Thank you, everyone, for joining us for the Global Plasma Summit here hosted by Jefferies. Up next, we're happy to introduce Amir London, CEO of Kamada. We have a 30-minute session. Amir will have a presentation for the entirety of the 30 minutes. If we have a few minutes toward the end, we can go to Q&A. Amir, thank you for joining us.
Of course. Thank you, Anthony, and thank you, all of you for joining us today. As Anthony mentioned, I will be presenting Kamada and I'm very honored for this invitation by Jefferies for the first Plasma Summit. Thank you very much for the opportunity.
So Kamada is a global specialty plasma-derived biopharmaceutical company. We are doing trading on the NASDAQ and Tel Aviv Exchange. 2 FDA approved product, the first one, GLASSIA in 2010; second one, KEDRRAB of 2017, and I will go through this portfolio in a minute.
In addition, we, of course, have products which are under clinical development. And
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
